Show simple item record

dc.contributor.authorMaissi, E
dc.contributor.authorMarteau, TM
dc.contributor.authorHankins, M
dc.contributor.authorMoss, S
dc.contributor.authorLegood, R
dc.contributor.authorGray, A
dc.date.accessioned2018-09-07T09:04:03Z
dc.date.issued2005-03-28
dc.identifier6
dc.identifier.citationBRITISH JOURNAL OF CANCER, 2005, 92 pp. 990 - 994
dc.identifier.issn0007-0920
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/2581
dc.identifier.doi10.1038/sj.bjc.6602411
dc.description.abstractState anxiety (S-STAI-6), distress (GHQ-12), concern and quality of life (EuroQoL-EQ-5D) 6 months after human papillomavirus (HPV) testing in women with borderline or mildly dyskaryotic smear test results were assessed based on a prospective questionnaire study, with 6-month follow-up after the smear test result. Two centres participated in an English pilot study of HPV testing. Participants included two groups of women receiving abnormal smear test results: (tested for HPV and found to be (a) HPV positive (n = 369) or (b) HPV negative (n = 252)) and two groups not tested for HPV (those receiving (c) abnormal smear test results (n = 102) or (d) normal smear test results (n = 288)). There were no differences in anxiety, distress or health-related quality of life between the four study groups at 6 months. Levels of concern about the smear test result remained elevated in all groups receiving an abnormal smear test result, and were highest in the group untested for HPV. Predictors of concern across all groups receiving an abnormal smear test were perceived risk of developing cancer, being HPV positive or untested for HPV, sexual health worries and the smear being a woman’s first smear test. The raised anxiety and distress observed in women immediately after being informed of an abnormal smear test result and that they are HPV positive was no longer evident at 6 months. Concern about the smear test result was however still raised in these women and those who tested negative for HPV, and particularly among those who did not undergo HPV testing.
dc.format.extent990 - 994
dc.languageeng
dc.language.isoeng
dc.publisherNATURE PUBLISHING GROUP
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleThe psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up
dc.typeJournal Article
rioxxterms.versionofrecord10.1038/sj.bjc.6602411
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2005-03-28
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfBRITISH JOURNAL OF CANCER
pubs.notesaffiliation: Marteau, TM (Reprint Author), Kings Coll London, Inst Psychiat, Dept Psychol, Hlth Psychol Sect, Thomas Guy House,Guys Campus, London SE1 9RT, England. Kings Coll London, Inst Psychiat, Dept Psychol, Hlth Psychol Sect, London SE1 9RT, England. Inst Canc Res, Canc Screening Evaluat Unit, Sutton SM2 5NG, Surrey, England. Univ Oxford, Hlth Econ Res Ctr, Dept Publ Hlth, Oxford OX3 7LF, England. keywords: human papillomavirus (HPV); anxiety; distress; smear test; quality of life keywords-plus: ABNORMAL PAP SMEAR; CONTROLLED TRIAL; SHORT-FORM; COLPOSCOPY; ANXIETY; QUESTIONNAIRE research-areas: Oncology web-of-science-categories: Oncology author-email: [email protected] orcid-numbers: Marteau, Theresa/0000-0003-3025-1129 Hankins, Matthew/0000-0002-1437-9117 number-of-cited-references: 17 times-cited: 55 usage-count-last-180-days: 0 usage-count-since-2013: 3 journal-iso: Br. J. Cancer doc-delivery-number: 908ZA unique-id: ISI:000227827500002 oa: gold_or_bronze da: 2018-09-06
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams/Cancer Screening Evaluation Unit (DoH)
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams/Cancer Screening Evaluation Unit (DoH)
pubs.volume92
pubs.embargo.termsNot known
icr.researchteamCancer Screening Evaluation Unit (DoH)en_US
dc.contributor.icrauthorMoss, Susan Maryen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0